Participation Statistics

ATTD 2018 aims:

• To bring together the world’s scientific experts to catalyze and advance scientific knowledge about Diabetes, present the most recent research findings, and promote and enhance scientific collaborations around the world.

• To bring together community leaders, scientists, and policy leaders to promote and enhance programmatic collaborations to more effectively address regional, national and local responses to Diabetes around the world and overcome barriers that limit access to prevention, care and services.

Industry Benefits of Supporting ATTD 2018

• Promotes cutting-edge scientific research
• Contributes to the advancement of Advanced Technologies and Treatments for Diabetes on an international level
• Offers a unique opportunity to exchange ideas with renowned professionals from across the world
• Provides an ideal networking forum
• Offers unique exposure to worldwide markets


YEAR CONFERENCE VENUE PARTICIPANTS
20081st ATTDPrague, Czech Republic742
2009
2nd ATTDAthens, Greece783
20103rd ATTDBasel, Switzerland904
20114th ATTDLondon, United Kingdom1,441
20125th ATTDBarcelona, Spain1,700
20136th ATTDParis, France2,117
20147th ATTDVienna, Austria2,0 84
20158th ATTDParis, France2,550
20169th ATTDMilan, Italy2,645
2017 10th ATTD Paris, France2,529


Profile of Attendees

The Audience ranges from various fields of expertise such as:
• Researchers and Clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers       as well as general & family medicine practitioners
• Key Opinion Leaders in Diabetes Technology
• MDs and Nurses with interest in Diabetes
• Start Up Companies Looking for Exposure
• Young Generation of MDs

​statistics from Paris 2017